This suggests that other potential markers would be explored to identify CF-SPID patients with a higher risk to evolve into CF or CFTR-RD and that would require a closer surveillance, like genetic modifiers [31], nasal potentials [4] or the analysis of CFTR protein activity on ex-vivo cells [32]. Here, CFTR is linked to cystic fibrosis.